Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02493062
Other study ID # FCI-22581
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date June 2013
Est. completion date December 20, 2017

Study information

Verified date January 2019
Source St. Louis University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is to review how the uterus heals after having open fetal surgery. Open fetal surgery causes a scar perhaps two: one from the open fetal surgery and a second from delivery by cesarean section; rarely, the same area of your uterus was used for both open fetal surgery and delivery. From other studies of surgery performed on a uterus, some of the uterine scars do not heal well. This study's intervention uses sterile saline to spread open the inside of the uterus. The saline is slowly injected into the uterus using a catheter. An ultrasound called a sonohysterogram is performed to take pictures of the uterus, its inside and the walls of the uterus. In this way, the healed areas from the uterine surgery can be seen with ultrasound and evaluated. This is performed at least 6 months after delivery.

Primary Outcome:

Measure the depth of the scar and location of the scar 6 months or longer after delivery.


Description:

This is an Investigator initiated, prospective study reviewing medical records and performing a sonohysterogram on non-pregnant women at 6 or more months after delivery of an infant who received open fetal repair.

An evaluation is completed at SSM Cardinal Glennon (CG), Fetal Care Institute (FCI) of a woman who has decided to have open fetal surgery to complete a fetal repair before the infant is born.

- After open fetal surgery participant will be monitored and delivered appropriately.

- After the infant is born investigators will review the mother's and infant's electronic health records and FCI database records

- 6 months or more after delivery of an infant who has received open fetal repair the participant will go to Saint Louis University (SLU) Care for a sonohysterogram to evaluate the healing process.


Recruitment information / eligibility

Status Terminated
Enrollment 35
Est. completion date December 20, 2017
Est. primary completion date December 20, 2017
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- SSM Cardinal Glennon Fetal Care Institute evaluation

- Received Open Fetal Surgery

- Open fetal surgery of myelomeningocele: maternal age of >= 18 yrs. and <=50 yrs.

- If a woman < 18 years old presented with a fetal tumor requiring open fetal repair, this would be done if deemed ethically sound by both CG and St. Mary's Health Center (SMHC) ethics committees. Given this, then the patient may qualify for this study. This is a RARE event.

- Agree to travel to SSM St. Mary's in St. Louis for sonohysterogram 6 or more months after delivery.

Exclusion Criteria:

- Presently pregnant

- Hysterectomy after delivery

- Menopause

- Using IUD (Intrauterine Device) for birth control

- There is no exclusion criteria for infants

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Sonohysterogram
The sonohysterogram can measure the size and depth of the uterine scar allowing better predictive values for future pregnancies.

Locations

Country Name City State
United States SSM Cardinal Glennon Fetal Care Institute Saint Louis Missouri

Sponsors (2)

Lead Sponsor Collaborator
St. Louis University SSM St. Mary’s Health Center Foundation.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cesarean Hysterotomy Myometrial Thickness Average myometrium thickness surrounding niche is measured by measuring Average thickness of the myometrium toward the cervix and toward the fundus resulting in the average myometrium thickness surrounding the niche, measured by the sonohysterogram. Minimum of 6 months after delivery.
Primary Cesarean Hysterotomy Site Myometrial Percentage of Thinning at the Niche Average myometrium will be calculated, measured by the sonohysterogram. The myometrium will be measured caudad and cephalad of the niche and averaged ((Caudad side in mm + Cephalad side in mm)/2)=Average myometrium thickness The myometrium at niche will be measured (niche mm). Average myometrium-niche mm= niche thinning (mm).
Niche thinning / Average myometrium thickness= Percentage of thinning at the niche.
Ex:
Average thickness at niche: 0.5 mm Caudad myometrium thickness: 1.5 mm Cephalad myometrium thickness: 1.5 mm
1.5mm + 1.5mm= 3mm/ 2= 1.5mm (average Myometrium Thickness)
1.5mm- 0.5mm = 1.0 mm (Niche thinning)
0.5mm / 1.0 mm (% of thinning at the niche)
Minimum of 6 months after delivery.
Primary Fetal Myelomeningocele Hysterotomy Site Myometrial Thickness Average myometrium thickness surrounding niche is measured by measuring average thickness of the myometrium to the right and left of the niche resulting in the average myometrium thickness surrounding the niche. This is measured by the sonohysterogram. Minimum of 6 months after delivery.
Primary Fetal Myelomeningocele Hysterotomy Site Myometrial Percentage of Thinning at the Niche Average myometrium will be calculated, measured by the sonohysterogram. The myometrium will be measure to the right and left of the niche and averaged ((Right side in mm + Left side in mm)/2)=Average myometrium thickness The myometrium at niche will be measured (niche mm). Average myometrium-niche mm= niche thinning (mm).
Niche thinning / Average myometrium thickness= Percentage of thinning at the niche.
Ex:
Average thickness at niche: 0.5 mm Right sided myometrium thickness: 1.5 mm Left sided myometrium thickness: 1.5 mm
1.5mm + 1.5mm= 3mm/ 2= 1.5mm (average Myometrium Thickness)
1.5mm- 0.5mm = 1.0 mm (Niche thinning)
0.5mm / 1.0 mm (% of thinning at the niche)
Minimum of 6 months after delivery.
Primary Percent of Participants With/Without Dehiscence (>80% Thinning of the Myometrium) at the Niche Yes >80% of thinning of the myometrium at the niche or No < 80% of thinning of the myometrium at the niche of the hysterotomy measured by the sonohysterogram. Minimum of 6 months after delivery.
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Completed NCT02408315 - Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE) Phase 3